Hadasit Bio Holdings Performance
| HSITFDelisted Stock | USD 0.12 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Hadasit Bio are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Hadasit Bio Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Hadasit Bio is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 5 M | |
| Total Cashflows From Investing Activities | 3.3 M |
Hadasit |
Hadasit Bio Relative Risk vs. Return Landscape
If you would invest 12.00 in Hadasit Bio Holdings on November 19, 2025 and sell it today you would earn a total of 0.00 from holding Hadasit Bio Holdings or generate 0.0% return on investment over 90 days. Hadasit Bio Holdings is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Hadasit, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Hadasit Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hadasit Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hadasit Bio Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Hadasit Bio Holdings is not yet fully synchronised with the market data | |
| Hadasit Bio Holdings has some characteristics of a very speculative penny stock | |
| Hadasit Bio Holdings has a very high chance of going through financial distress in the upcoming years | |
| Hadasit Bio Holdings has accumulated about 15.02 M in cash with (2.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 75.0% of the company shares are held by company insiders |
Hadasit Bio Fundamentals Growth
Hadasit Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Hadasit Bio, and Hadasit Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hadasit Pink Sheet performance.
| Return On Equity | -0.44 | |||
| Return On Asset | -0.0296 | |||
| Current Valuation | (988.32 K) | |||
| Shares Outstanding | 11.09 M | |||
| Price To Earning | 1.23 X | |||
| Price To Book | 0.72 X | |||
| Price To Sales | 1,381 X | |||
| EBITDA | 28.67 M | |||
| Cash And Equivalents | 15.02 M | |||
| Cash Per Share | 1.36 X | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 0.98 X | |||
| Cash Flow From Operations | (2.1 M) | |||
| Earnings Per Share | 0.61 X | |||
| Total Asset | 66.41 M | |||
| Retained Earnings | (125 M) | |||
| Current Asset | 38 M | |||
| Current Liabilities | 4 M | |||
About Hadasit Bio Performance
By analyzing Hadasit Bio's fundamental ratios, stakeholders can gain valuable insights into Hadasit Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Hadasit Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Hadasit Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. Hadasit Bio-Holdings Ltd was founded in 2005 and is based in Jerusalem, Israel. Hadasit Bio is traded on OTC Exchange in the United States.Things to note about Hadasit Bio Holdings performance evaluation
Checking the ongoing alerts about Hadasit Bio for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Hadasit Bio Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Hadasit Bio Holdings is not yet fully synchronised with the market data | |
| Hadasit Bio Holdings has some characteristics of a very speculative penny stock | |
| Hadasit Bio Holdings has a very high chance of going through financial distress in the upcoming years | |
| Hadasit Bio Holdings has accumulated about 15.02 M in cash with (2.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 75.0% of the company shares are held by company insiders |
- Analyzing Hadasit Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hadasit Bio's stock is overvalued or undervalued compared to its peers.
- Examining Hadasit Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hadasit Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hadasit Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hadasit Bio's pink sheet. These opinions can provide insight into Hadasit Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Hadasit Pink Sheet
If you are still planning to invest in Hadasit Bio Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hadasit Bio's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |